- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07927530
Ultrasound-Guided Thoracolumbar Fascia Injection for Chronic Low Back Pain in Patients With Type 2 Diabetes
Efficacy of Ultrasound-Guided Thoracolumbar Fascia Injection in the Treatment of Chronic Low Back Pain in Patients With Type 2 Diabetes Mellitus: A Randomized Controlled Trial
This prospective, randomized, controlled clinical trial aims to evaluate the efficacy of ultrasound-guided thoracolumbar fascia (TLF) injection as an adjunct to standard conservative treatment in patients with type 2 diabetes mellitus and chronic nonspecific low back pain.
A total of 60 patients aged 18-65 years, diagnosed with type 2 diabetes mellitus for at least one year and experiencing chronic nonspecific low back pain for at least three months, will be enrolled. Eligible participants will be randomly assigned to two groups. The intervention group will receive ultrasound-guided thoracolumbar fascia injection in addition to standard conservative treatment, while the control group will receive standard conservative treatment alone, consisting of patient education and a structured exercise program.
Clinical assessments will be performed at baseline and at 1 and 3 months after treatment. Treatment outcomes will include pain intensity measured using the Numeric Rating Scale (NRS), functional disability assessed using the Oswestry Disability Index (ODI), pressure pain threshold (PPT) measured by algometry, and analgesic consumption.
Thoracolumbar fascia thickness will be measured using ultrasonography at baseline to investigate its potential association with treatment response. Diabetes-related characteristics, including HbA1c levels, diabetes duration, and peripheral neuropathy status, will also be recorded.
The primary objective is to determine whether adding ultrasound-guided thoracolumbar fascia injection to standard conservative treatment provides greater improvement in pain intensity and functional disability compared with standard conservative treatment alone. The study will also explore whether baseline thoracolumbar fascia thickness and diabetes-related characteristics are associated with clinical outcomes.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Hatice Zehra FERHATLAR, MD
- Phone Number: 05367387869
- Email: haticezehraferhatlar@gmail.com
Study Locations
-
-
Istanbul
-
Küçükçekmece, Istanbul, Turkey (Türkiye), 34307
- Recruiting
- Kanuni Sultan Suleyman Training and Research Hospital
-
Contact:
- Hatice Zehra FERHATLAR, MD
- Phone Number: 05367387869
- Email: haticezehraferhatlar@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
**Inclusion Criteria:**
- Age between 18 and 65 years.
- Diagnosis of type 2 diabetes mellitus for at least 1 year.
- Chronic low back pain lasting at least 3 months.
- Nonspecific or mechanical low back pain.
- Baseline pain intensity of ≥4 on the Numeric Rating Scale (NRS).
- Pain or tenderness on palpation over the thoracolumbar fascia region.
- Willingness to participate in the study.
- Provision of written informed consent.
**Exclusion Criteria:**
- Radiculopathy or significant neurological deficits.
- Neurogenic claudication due to spinal stenosis.
- Spinal tumor or infection.
- History or presence of vertebral fracture.
- Inflammatory rheumatic disease.
- Spinal surgery within the previous 6 months.
- Injection in the lumbar region within the previous 3 months.
- Anticoagulant therapy or conditions contraindicating injection.
- Active infection at the injection site.
- Severe systemic disease, including advanced renal failure.
- Uncontrolled diabetic metabolic condition.
- Pregnancy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Thoracolumbar Fascia Injection Group
|
A single ultrasound-guided thoracolumbar fascia injection will be performed with the patient in the prone position under aseptic conditions. Using an in-plane technique, a 22-gauge needle will be advanced into the middle layer of the thoracolumbar fascia between the quadratus lumborum and erector spinae muscles at the L4 level. Correct needle placement will be confirmed by hydrodissection using approximately 2 mL of local anesthetic. Subsequently, 10 mL of 0.25% bupivacaine and 40 mg of methylprednisolone acetate will be administered into the interfascial plane. Standard conservative treatment will consist of structured patient education and a home-based exercise program. The exercise program will include lumbopelvic and core stabilization exercises, abdominal and paraspinal muscle strengthening, hip muscle strengthening, lower extremity stretching, and aerobic activity as tolerated. Participants will receive instructions on correct exercise techniques, maintaining daily activities, and avoiding prolonged bed rest. The program will be recommended for regular home practice throughout the study period. |
|
Active Comparator: Standard Conservative Treatment Group
|
Standard conservative treatment will consist of structured patient education and a home-based exercise program. The exercise program will include lumbopelvic and core stabilization exercises, abdominal and paraspinal muscle strengthening, hip muscle strengthening, lower extremity stretching, and aerobic activity as tolerated. Participants will receive instructions on correct exercise techniques, maintaining daily activities, and avoiding prolonged bed rest. The program will be recommended for regular home practice throughout the study period. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in Low Back Pain Intensity Measured by the Numeric Rating Scale (NRS)
Time Frame: Baseline, Month 1, and Month 3
|
Baseline, Month 1, and Month 3
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in Functional Disability Measured by the Oswestry Disability Index (ODI)
Time Frame: Baseline, Month 1, and Month 3
|
Baseline, Month 1, and Month 3
|
|
Change in Pressure Pain Threshold (PPT) Measured by Algometry
Time Frame: Baseline, Month 1, and Month 3
|
Baseline, Month 1, and Month 3
|
|
Change in Analgesic Consumption During Follow-up
Time Frame: Baseline to Month 3
|
Baseline to Month 3
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Ahiskalioglu A, Yayik AM, Celik EC, Aydin ME, Uzun G. Ultrasound guided modified Thoracolumbar Interfascial Plane block for low back pain management. J Clin Anesth. 2019 May;54:138-139. doi: 10.1016/j.jclinane.2018.11.010. Epub 2018 Nov 28. No abstract available.
- Okmen BM, Okmen K. Effectiveness of the Ultrasound-Guided Interfascial Injection Applied in Addition to Physical Therapy Applications in Chronic Low Back Pain: A Quasi-Experimental Study. Eurasian J Med. 2024 Feb;56(1):56-60. doi: 10.5152/eurasianjmed.2024.23286.
- Lv Y, Wu J, Xu Y, Pu S, Li C, Du D. A novel approach to ultrasound-guided L3-4 thoracolumbar fascia injection for chronic pain after spine surgery: a prospective pilot study. BMC Anesthesiol. 2025 May 15;25(1):243. doi: 10.1186/s12871-025-03046-6.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- TLF-DM-RCT-2026
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.